Cite
MLA Citation
Erik Lawitz et al.. “High Efficacy of Sofosbuvir/Velpatasvir Plus GS‐9857 for 12 Weeks in Treatment‐Experienced Genotype 1‐6 HCV‐Infected Patients, Including Those Previously Treated with Direct‐Acting Antivirals: 2016 ACG Presidential Poster Award.” American journal of gastroenterology, vol. 111, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100123024195.0x000016